Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms

다국어 초록 (Multilingual Abstract)

Metabolic dysfunction-associated steatotic liver disease (MASLD) has profound adverse effects on bone health and homeostasis. MASLD appears to be associated with changes in bone mineral density (BMD) and fracture rate. However, the data are ambiguous and conflicting. Although several studies have shown that children and adolescents with MASLD have decreased BMD, the data on the prevalence of fragility fractures among children are scarce. In adults, increasing evidence suggests that MASLD decreases BMD and increases the risk of fragility fractures, which appears to be due to deterioration of bone architecture in addition to a decrease in BMD. Effects of MASLD on bone health may also be age- and race-specific. MASLD does not seem to increase fracture risk in children and adolescents but increases the risk of fractures in elderly men, especially those of Asian origin. From a mechanistic perspective, bone remodeling is a continuous process between osteoblasts (bone-forming) and osteoclasts (bone-resorbing), with any imbalance resulting in metabolic bone disease. In individuals with MASLD, loss of anabolic insulin receptor signaling (insulin resistance) in osteoblasts and increased receptor activator of nuclear factor κB (RANK)/RANK ligand signaling in osteoclasts (proinflammatory cytokines) swings the pendulum toward accelerated bone loss. These processes are further complicated by the concomitant presence of obesity, type 2 diabetes mellitus, or sarcopenia in individuals with MASLD. This study reviews the current literature associated with the effects of MASLD on BMD and fragility fractures in children/adolescents and adults. This review also discusses the pathomechanisms that link MASLD with changes in BMD and fragility fractures.

참고문헌 (Reference)

• 1 장은재 ; 양혜란 ; 이대용, "Vitamin D status and bone mineral density in obese children with nonalcoholic fatty liver disease" 30 : 1821-1827, 2015
• 2 Khanmohammadi S, "Toll-like receptors and metabolic(dysfunction)-associated fatty liver disease" 185 : 106507-, 2022
• 3 Salari N, "The global prevalence of osteoporosis in the world : a comprehensive systematic review and meta-analysis" 16 : 609-, 2021
• 4 Shen Y, "The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019" 13 : 882241-, 2022
• 5 Purnak T, "The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease" 124 : 526-531, 2012
• 6 Xia MF, "The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women" 14 : 11-, 2016
• 7 Fuller K, "TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL" 143 : 1108-1118, 2002
• 8 Lam J, "TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand" 106 : 1481-1488, 2000
• 9 Mantovani A, "Systematic review with meta-analysis : non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density" 49 : 375-388, 2019
• 10 Kanazawa I, "Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus" 18 : 1675-1681, 2007
• 11 Cavati G, "Role of advanced glycation end-products and oxidative stress in type-2-diabetes-induced bone fragility and implications on fracture risk stratification" 12 : 928-, 2023
• 12 Wester A, "Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease : a nationwide population-based cohort study" 292 : 492-500, 2022
• 13 Yilmaz Y, "Review article : non-alcoholic fatty liver disease and osteoporosis : clinical and molecular crosstalk" 36 : 345-352, 2012
• 14 Kim Min-Ji ; Kim Min-Su ; Lee Han-Byul ; Roh Jae-Hyung ; Jeon Jae-Han, "Relationship between the high fatty liver index and risk of fracture" 17 : 119-129, 2023
• 15 Sun Y, "Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity : a meta-analysis" 12 : 199-207, 2019
• 16 Mosca A, "Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents" 38 : 2301-2308, 2018
• 17 Xie R, "Relationship between non-alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density" 13 : 857110-, 2022
• 18 성지선 ; Seung Ho Ryu ; 송윤미 ; 정해관, "Relationship between non-alcoholic fatty liver disease and decreased bone mineral density : a retrospective cohort study in Korea" 53 : 342-352, 2020
• 19 Pramojanee SN, "Possible roles of insulin signaling in osteoblasts" 39 : 144-151, 2014
• 20 Kakino S, "Pivotal role of TNF-α in the development and progression of nonalcoholic fatty liver disease in a murine model" 50 : 80-87, 2018
• 21 Kuchay MS, "Pathophysiological mechanisms underlying MAFLD" 14 : 1875-1887, 2020
• 22 Chen R, "Obesity and skeletal fragility" 109 : e466-e477, 2024
• 23 Rinonapoli G, "Obesity and bone : a complex relationship" 22 : 13662-, 2021
• 24 Umehara T, "Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density : cross-sectional study in U. S. adults" 13 : e0197900-, 2018
• 25 Arturi F, "Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I" 96 : E1640-E1644, 2011
• 26 Fusco A, "Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels" 77 : 531-536, 2012
• 27 Su YH, "Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults : a systematic review and metaanalysis" 38 : 1092-1103, 2023
• 28 Mantovani A, "Nonalcoholic fatty liver disease and bone mineral density in children and adolescents : specific considerations for future studies" 64 : 898-900, 2019
• 29 Kuchay MS, "Non-alcoholic fatty liver disease-related fibrosis and sarcopenia : an altered liver-muscle crosstalk leading to increased mortality risk" 80 : 101696-, 2022
• 30 Loosen SH, "Non-alcoholic fatty liver disease(NAFLD)is associated with an increased incidence of osteoporosis and bone fractures" 60 : 1221-1227, 2022
• 31 Pardee PE, "Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children" 35 : 248-254, 2012
• 32 Hassan AM, "Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients" 13 : 4353-, 2023
• 33 Khanmohammadi S, "NODlike receptors in the pathogenesis of metabolic(dysfunction)-associated fatty liver disease : therapeutic agents targeting NODlike receptors" 17 : 102788-, 2023
• 34 Ciardullo S, "NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population" 106 : e2856-e2865, 2021
• 35 Wah-Kheong Chan ; Kee-Huat Chuah ; Ruveena Bhavani Rajaram ; Lee-Ling Lim ; Jeyakantha Ratnasingam ; Shireene Ratna Vethakkan, "Metabolic dysfunction-associated steatotic liver disease(MASLD) : a state-of-the-art review" 32 : 197-213, 2023
• 36 Sumida Y, "Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of nonalcoholic fatty liver disease" 45 : 771-781, 2015
• 37 Kuchay MS, "Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease" 36 : 3204-3211, 2021
• 38 Shieh A, "Longitudinal associations of insulin resistance with change in bone mineral density in midlife women" 7 : e162085-, 2022
• 39 Barchetta I, "Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease" 17 : 357-366, 2023
• 40 Kuchay MS, "Liver cirrhosis and sarcopenia : a dreadful combination" 11 : 729-731, 2022
• 41 Fulzele K, "Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition" 142 : 309-319, 2010
• 42 Ilesanmi-Oyelere BL, "Inflammatory markers and bone health in postmenopausal women : a cross-sectional overview" 16 : 15-, 2019
• 43 Bhatt SP, "Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India" 230 : 157-163, 2013
• 44 Chen HJ, "Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease : a population-based retrospective cohort study" 97 : e12835-, 2018
• 45 Yu Z, "Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes" 11 : e220174-, 2022
• 46 Shen Z, "Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease : a cohort study" 182 : 157-164, 2020
• 47 Kaya M, "Increased bone mineral density in patients with non-alcoholic steatohepatitis" 5 : 627-634, 2013
• 48 Lecka-Czernik B, "High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity" 410 : 35-41, 2015
• 49 Chun LF, "Hepatic steatosis is negatively associated with bone mineral density in children" 233 : 105-111, 2021
• 50 Yoon JW, "Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease" 15 : 1347-1355, 2021
• 51 Labayen I, "Hepatic fat content and bone mineral density in children with overweight/obesity" 84 : 684-688, 2018
• 52 Zhao LJ, "Correlation of obesity and osteoporosis : effect of fat mass on the determination of osteoporosis" 23 : 17-29, 2008
• 53 Pirgon O, "Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease" 75 : 189-195, 2011
• 54 Gertz ER, "Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women : a 1-year investigation" 13 : 277-282, 2010
• 55 Sheu A, "Bone mineral density : testing for osteoporosis" 39 : 35-39, 2016
• 56 Damani JJ, "Associations between inflammatory mediators and bone outcomes in postmenopausal women : a cross-sectional analysis of baseline data from the Prune Study" 16 : 639-663, 2023
• 57 Wang Y, "Association of nonalcoholic fatty liver disease with osteoporotic fractures : a cross-sectional retrospective study of Chinese individuals" 9 : 408-, 2018
• 58 Yang HJ, "Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men" 28 : 338-344, 2016
• 59 Chung GE, "Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years : a nationwide population-based study" 14 : 1156996-, 2023
• 60 Xu L, "Association between serum growth hormone levels and nonalcoholic fatty liver disease : a cross-sectional study" 7 : e44136-, 2012
• 61 Li M, "Association between nonalcoholic fatty liver disease(NAFLD)and osteoporotic fracture in middle-aged and elderly Chinese" 97 : 2033-2038, 2012
• 62 Mantovani A, "Association between nonalcoholic fatty liver disease and reduced bone mineral density in children : a meta-analysis" 70 : 812-823, 2019
• 63 Mantovani A, "Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes" 45 : 347-355, 2019
• 64 Lee DY, "Association between non-alcoholic fatty liver disease and bone mineral density in postmenopausal women" 21 : 498-501, 2018
• 65 Li BT, "Association between liver fat and bone density is confounded by general and visceral adiposity in a community-based cohort" 29 : 595-600, 2021
• 66 Shin D, "Association between insulin resistance and bone mass in men" 99 : 988-995, 2014
• 67 Lee SH, "Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults" 39 : 1329-1336, 2016
• 68 Lee HJ, "Association between 10-year fracture probability and nonalcoholic fatty liver disease with or without sarcopenia in Korean men : a nationwide populationbased cross-sectional study" 12 : 599339-, 2021
• 69 Hansen SG, "Are nonalcoholic fatty liver disease and bone mineral density associated? : a cross-sectional study using liver biopsy and dual-energy X-ray absorptiometry" 7 : e10714-, 2023
• 70 Pacifico L, "Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease" 19 : 4007-4014, 2013
• 71 Pouresmaeili F, "A comprehensive overview on osteoporosis and its risk factors" 14 : 2029-2049, 2018